RELATED STUDY
Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.
Key Findings: CBD reduced OCD-like behavior in the test animals.
Type of Study: Animal Study
Study Result: Positive
Study Location(s): United Kingdom
Year of Pub: 2012
Cannabinoids Studied: Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabivarin (THCV)
Phytocannabinoid Source: Unspecified
Dosage: CBD (120 mg/kg, ip and oral)
Route of Administration: Injection, Oral (Ingestion)
Link to study
